- Home
- VRAX vs LDWY Comparison
VRAX vs LDWY Comparison
Compare VRAX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- LDWY
- Stock Information
- Founded
- VRAX 2013
- LDWY 1990
- Country
- VRAX United Kingdom
- LDWY United States
- Employees
- VRAX N/A
- LDWY N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LDWY Advertising
- Sector
- VRAX Health Care
- LDWY Consumer Discretionary
- Exchange
- VRAX Nasdaq
- LDWY Nasdaq
- Market Cap
- VRAX 4.7M
- LDWY 9.2M
- IPO Year
- VRAX 2022
- LDWY 1991
- Fundamental
- Price
- VRAX $0.90
- LDWY $5.07
- Analyst Decision
- VRAX Strong Buy
- LDWY
- Analyst Count
- VRAX 1
- LDWY 0
- Target Price
- VRAX $3.00
- LDWY N/A
- AVG Volume (30 Days)
- VRAX 66.0K
- LDWY 4.1K
- Earning Date
- VRAX 02-05-2025
- LDWY 08-18-2025
- Dividend Yield
- VRAX N/A
- LDWY N/A
- EPS Growth
- VRAX N/A
- LDWY N/A
- EPS
- VRAX N/A
- LDWY N/A
- Revenue
- VRAX $6,331.00
- LDWY $42,183,000.00
- Revenue This Year
- VRAX $217,274.83
- LDWY N/A
- Revenue Next Year
- VRAX N/A
- LDWY N/A
- P/E Ratio
- VRAX N/A
- LDWY N/A
- Revenue Growth
- VRAX N/A
- LDWY 425.12
- 52 Week Low
- VRAX $0.74
- LDWY $3.02
- 52 Week High
- VRAX $9.00
- LDWY $5.53
- Technical
- Relative Strength Index (RSI)
- VRAX 56.08
- LDWY 53.73
- Support Level
- VRAX $0.84
- LDWY $4.10
- Resistance Level
- VRAX $0.98
- LDWY $5.39
- Average True Range (ATR)
- VRAX 0.08
- LDWY 0.31
- MACD
- VRAX 0.02
- LDWY -0.00
- Stochastic Oscillator
- VRAX 75.94
- LDWY 75.19
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.